User was viewed 679 times (total).
Kristina S. Azlin is a partner in the Los Angeles office of Holland & Knight and is a member of the West Coast Litigation Group. Ms. Azlin has extensive federal and state litigation experience and has represented clients in a wide array of complex civil matters, including class action defense, contract disputes, intellectual property infringement, business fraud and product liability actions. She also has significant experience defending actions involving the federal False Claims Act (FCA), as well as state versions of the FCA.
Ms. Azlin is experienced in all phases of state and federal litigation practice, including interviewing witnesses and conducting investigations, taking and defending depositions, locating and working with expert witnesses, preparing and responding to complex written discovery, examining and cross-examining lay and expert witnesses during trial, and extensive pretrial and post-trial law and motion practice. She assists in representing both plaintiffs and defendants in securing favorable results.
This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.